Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 23, Issue 22, 2005, Pages 4999-5006

  Hamada, Chikuma ^a   Tanaka, Fumihiro ^a   Ohta, Mitsuo ^a   Fujimura, Shigefumi ^a   Kodama, Ken ^a   Imaizumi, Munehisa ^a   Wada, Hiromi ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM; UFT; ANTINEOPLASTIC ANTIMETABOLITE; TEGAFUR;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; ADENOCARCINOMA; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; SURVIVAL;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; SURVIVAL ANALYSIS; TEGAFUR;

EID: 24644514458     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.09.017     Document Type: Article

References (31)

1. Mountain CF: Revisions in the international system for staging lung cancer. Chest 116:1710-1717, 1997
2. Naruke T, Tsuchiya R, Kondo H, et al: Implication of staging in lung cancer. Chest 112: 242s-248s, 1997
3. PORT Meta-analysis Trialists Group: Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352:257-263, 1998
4. Scagliotti GV, Fossati R, Torri V, et al: Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Nat Cancer Inst 95:1453-1461, 2003
5. Non-small Cell Lung Cancer Collaborative Group: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899-909, 1995
6. The International Adjuvant Lung Cancer Trial Collaborative Group: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 350:351-360, 2004
7. Winton TL, Livingston R, Johnson D, et al: A prospective randomized trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage IB and II non small cell lung cancer (NSCLC) Intergroup JBR 10. J Clin Oncol 22:621s, 2004 (abstr 7018)
8. Strauss GM, Maddaus MA, Johnstone DW, et al: Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 22:621s, 2004 (abstr 7019)
9. Taguchi T: Clinical application of biochemical modulation in cancer chemotherapy: Biochemical modulation for 5-FU. Oncology 54:12-18, 1997 (suppl 1)
10. Wada H, Hitomi S, Teramatsu T, et al: Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. J Clin Oncol 14:1048-1054, 1996
11. Kato H, Ichinose Y, Ohta M, et al: A randomized trail of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350:1713-1721, 2004
12. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomised trails. Lancet 351: 1451-1467, 1998
13. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomised trails. Lancet 352:930-942, 1998
14. Colorectal Cancer Collaborative Group: Adjuvant radiotherapy for rectal cancer: A systemic overview of 8,507 patients from 22 randomised trials. Lancet 358:1291-1304, 2001
15. Endo C, Saito Y, Iwanami H, et al: A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan study group for lung cancer surgery. Lung Cancer 40:181-186, 2003
16. Fukushima M, Tsushima T, Ito H, et al: A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer. Jpn J Cancer Chemother 23:303-309, 1996
17. The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan): A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). Eur J Surg Oncol 21:69-77, 1995
18. Wada H, Miyahara R, Tanaka F, et al: Postoperative adjuvant chemotherapy with PVM (Cisplatin+Vindesine+Mitomycin C) and UFT (Uracil+Tegaful) a randomized clinical trial: West Japan Study Group for lung cancer surgery (WJSG). Eur J Cardiothorac Surg 15:438-443, 1999
19. Nakagawa M, Tanaka F, Tsubota N, et al: A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: The west Japan study group for lung cancer surgery (WJSG), the 4th study. Ann Oncol 16:75-80, 2005
20. Tada H, Yasumitsu T, Iuchi K, et al: Randomized study of adjuvant chemotherapy for completely resected non-small cell lung cancer. Proc J Clin Oncol 21:313a, 2002 (abstr 1250)
21. Imaizumi M: A randomized trial of postoperative adjuvant chemotherapy for p-stage I non-small cell lung cancer (4th cooperative study). Lung Cancer 41:S2, 2003 (abstr O180)
22. Kato T, Ohashi Y, Nakazato H, et al: Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: Multicenter prospective randomized trial. Langenecks Arch Surg 386:575-581, 2001
23. Sakamoto J, Hamada C, Yasutomi M, et al: Efficacy of oral UFT as adjuvant chemotherapy after resection of rectal Cancer: Meta-analysis of 5-year results from four randomized trials in 1815 patients. Proc Am Soc Clin Oncol 22:270, 2003 (abstr 1082)
24. Ogita M, Uchino J, Asaishi K, et al: Efficacy of UFT plus tamoxifen for estrogen-receptor-positive breast cancer and tamoxifen plus UFT for estrogen-receptor-negative breast cancer. Clin Drug Invest 23:689-699, 2003
25. Kasumi F, Yoshimoto M, Uchino J, et al: Meta-analysis of five studies on tegafur plus uracil (UFT) as post-operative adjuvant chemotherapy for breast cancer. Oncology 64:146-153, 2003
26. Kurebayashi J, Nakatsuka M, Fujioka A, et al: Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice. Clin Cancer Res 3:653-659, 1997
27. Miyahara R, Nakagawa T, Ishikawa S, et al: UFT inhibits lung metastases in spontaneous metastasis model of lung cancer. Thorac Cardiovasc Surg 53:118-121, 2005
28. Sedrakyan A, Der Meulen JV, O'Byrne K, et al: Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis. Gen Thorac Surg 128:414-419, 2004
29. Hotta K, Matsuo K, Ueoka H, et al: Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: Reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 22:3860-3867, 2004
30. Piedbois P, Mondor H, Buyse M: Meta-analyses based on abstracted data: A step in the right direction, but only s first step. J Clin Oncol 22:3839-3841, 2004
31. Borner MM, Schoffski P, de Wit R, et al: Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: A randomised crossover trial inadvanced colorectal cancer. Eur J Cancer 38: 349-358, 2002